Guidelines from the American Diabetes Association (ADA) and the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) recommend type 2 diabetes mellitus patients receive annual measurement of estimated glomerular filtration rate (eGFR) and annual screening for albuminuria, which is identified by calculating the urinary albumin to creatinine ratio (ACR) (9,12). This evidence concerns the gene ALB and diabetes mellitus.